How different sequencing tools will fare
Scientia Advisors in the News
GEN quotes Harry Glorikian in article "Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing"
November 22, 2011In this article, Genetic Engineering & Biotechnology quotes Harry Glorikian of Scientia Advisors on the disappointing results of sequencing activities. You can view Harry's comments in the full article on Genetic Engineering & Biotechnology News' website.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
